October 25, 2016 9:50 AM ET

Life Sciences Tools and Services

Company Overview of Personalis, Inc.

Company Overview

Personalis, Inc., a precision medicine company, offers next–generation sequencing-based clinical diagnostic and research services for cancer and inherited genetic diseases. The company provides researchers and clinicians DNA sequencing and interpretation of human exomes and genomes. It also offers ACE Platform, a sequencing and analysis solution to address research and diagnostic questions; ACE ImmunoID, a solution to obtain genomic and transcriptomic data for neoantigen identification; Athena Diagnostics, a diagnostic test for neurological disease cases; and DNA Analysis pipeline for cancer performs alignment and variant calling for germline and somatic variants. In addition, the company pr...

1330 O’Brien Drive

Menlo Park, CA 94025

United States

Founded in 2011





Key Executives for Personalis, Inc.

Co-Founder, Chief Executive Officer and Director
Co-Founder and Member of Clinical & Scientific Advisory Board
Co-Founder and Member of Clinical & Scientific Advisory Board
Co-Founder and Member of Clinical & Scientific Advisory Board
Co-Founder and Member of Clinical & Scientific Advisory Board
Compensation as of Fiscal Year 2016.

Personalis, Inc. Key Developments

Personalis Wins Task Order from US Department of Veterans

Personalis, Inc. announced that the company has been awarded an additional task order by the US Department of Veterans Affairs (VA) to provide whole genome DNA sequencing and data analysis services for the VA’s Million Veteran Program (MVP). Personalis will perform whole genome DNA sequencing, and bioinformatics analysis using its secure computing infrastructure and proprietary algorithms. The sequencing will be performed in Personalis’ recently expanded laboratory in Menlo Park, CA. This additional order will bring the total of whole genome deliveries by Personalis to the VA to over 10,000.

Personalis, Inc. Announces Partnership with Mt. Sinai Services to Offer ACE Platform

Personalis, Inc. announced that the company has entered into a letter of intent with Mount Sinai Services, Inc. The LOI contains broad terms for the development of a partnership framework for Personalis and Mount Sinai Services to offer the Personalis patented, and CLIA validated ACE sequencing and analysis technology for clinical diagnostic and research tumor molecular profile sequencing and analysis and immuno-oncology sequencing clinical trials for customers throughout Canada. The ACE Platform incorporates proprietary sample prep and sequencing processes which produce the highest levels of gene finishing and coverage of difficult-to-sequence regions. The ACE ImmunoID service offers multiple solutions for the comprehensive analysis of tumor mutation burden and neoantigen identification including the ACE Cancer Exome and Transcriptome covering over 20,000 genes and the ACE Cancer DNA/RNA Panel available with over 1,400 genes. The Personalis ACE assays and informatics platform achieves coverage and sensitivity enabling variants to be identified more accurately and reliably in regions that may be completely missed by typical exomes, transcriptomes, and panels. The ACE assays together with advanced informatics are CLIA validated to enable clinical diagnostic and clinical trials use.

Personalis, Inc. Presents at The UBS 2016 Global Healthcare Conference, May-23-2016

Personalis, Inc. Presents at The UBS 2016 Global Healthcare Conference, May-23-2016 . Venue: The Grand Hyatt Hotel, 109 East 42nd Street at Grand Central Terminal, New York, New York, United States. Speakers: John West, Co-Founder, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Personalis, Inc., please visit www.personalis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.